Join us for a lunch symposium at ASC

"The Power of Two in the Post-Vaccine Era: Real-World Use of Cytology and Extended Genotyping for Screening and Management of Cervical, Anal, and Head and Neck Cancers,” explores how combining cytology with extended high-risk HPV genotyping provides greater clinical value than either approach alone. The session highlights how these complementary tools can improve risk stratification, support ASCCP- and CAP-aligned management decisions, and guide screening and follow-up strategies across multiple HPV-associated disease sites.

Join Ben Shuler, MBA, CT(ASCP), Cytopathology Manager at Indiana University Health, as he examines the impact of HPV vaccination on disease patterns and explains why more detailed genotype information is becoming increasingly important in the post-vaccine era. Using real-world experience from Indiana University Health, he will discuss the application of extended HPV genotyping for cervical, anal, and head and neck cancer programs, highlighting opportunities for earlier detection, more personalized patient management, and improved utilization of laboratory data in modern screening and diagnostic strategies.